SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mimedx Group, Inc. – ‘10-K’ for 12/31/15 – ‘EX-101.SCH’

On:  Monday, 2/29/16, at 4:25pm ET   ·   For:  12/31/15   ·   Accession #:  1376339-16-138   ·   File #:  1-35887

Previous ‘10-K’:  ‘10-K’ on 3/13/15 for 12/31/14   ·   Next:  ‘10-K/A’ on 2/22/17 for 12/31/15   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   4 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/29/16  Mimedx Group, Inc.                10-K       12/31/15   84:7.4M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    787K 
 2: EX-21.1     Subsidiaries List                                   HTML     22K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML     24K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     30K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     25K 
14: R1          Document and Entity Information                     HTML     51K 
15: R2          Consolidated Balance Sheets                         HTML    100K 
16: R3          Consolidated Balance Sheets (Parenthetical)         HTML     46K 
17: R4          Consolidated Statements of Operations               HTML     75K 
18: R5          Consolidated Statements of Stockholders' Equity     HTML    106K 
19: R6          Consolidated Statements of Stockholders' Equity     HTML     27K 
                (Parenthetical)                                                  
20: R7          Consolidated Statements of Cash Flows               HTML    108K 
21: R8          Nature of Business                                  HTML     28K 
22: R9          Significant Accounting Policies                     HTML     66K 
23: R10         Liquidity and Capital Resources                     HTML     28K 
24: R11         Cash Equivalents and Short Term Investments         HTML     26K 
25: R12         Inventories                                         HTML     37K 
26: R13         Investments                                         HTML     25K 
27: R14         Property and Equipment                              HTML     41K 
28: R15         Intangible Assets and Royalty Agreement             HTML     63K 
29: R16         Long-Term Debt                                      HTML     33K 
30: R17         Net Income (loss) Per Share                         HTML     50K 
31: R18         Common Stock Placements                             HTML     32K 
32: R19         Equity                                              HTML    138K 
33: R20         Income Taxes                                        HTML     92K 
34: R21         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     54K 
                Investing and Financing Activities                               
35: R22         401k Plan                                           HTML     29K 
36: R23         Commitments and Contingencies                       HTML     63K 
37: R24         Quarterly Financial Data (Unaudited)                HTML     93K 
38: R25         Subsequent Events                                   HTML     28K 
39: R26         Schedule II - Valuation and Qualifying Accounts     HTML     71K 
40: R27         Significant Accounting Policies (Policies)          HTML    129K 
41: R28         Inventories (Tables)                                HTML     36K 
42: R29         Property and Equipment (Tables)                     HTML     38K 
43: R30         Intangible Assets and Royalty Agreement (Tables)    HTML     63K 
44: R31         Net Income (loss) Per Share (Tables)                HTML     51K 
45: R32         Equity (Tables)                                     HTML    137K 
46: R33         Income Taxes (Tables)                               HTML     86K 
47: R34         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     53K 
                Investing and Financing Activities (Tables)                      
48: R35         Commitments and Contingencies (Tables)              HTML     31K 
49: R36         Quarterly Financial Data (Unaudited) (Tables)       HTML     91K 
50: R37         Nature of Business (Details)                        HTML     25K 
51: R38         Significant Accounting Policies (Details)           HTML     65K 
52: R39         Liquidity and Capital Resources (Details)           HTML     46K 
53: R40         Cash Equivalents and Short Term Investments         HTML     33K 
                (Details)                                                        
54: R41         Inventories (Details)                               HTML     37K 
55: R42         Investments (Details)                               HTML     27K 
56: R43         Property and Equipment (Details)                    HTML     51K 
57: R44         Intangible Assets and Royalty Agreement Intangible  HTML     88K 
                Asssets Activity Summary (Details)                               
58: R45         Intangible Assets and Royalty Agreement Expected    HTML     39K 
                Future Amortization of Intangible Assets (Details)               
59: R46         Long-Term Debt (Details)                            HTML     79K 
60: R47         Net Income (loss) Per Share Computation of Basic    HTML     50K 
                and Dilutive Net Loss per Share (Details)                        
61: R48         Net Income (loss) Per Share Summary of              HTML     35K 
                Antidilutive Securities (Details)                                
62: R49         Common Stock Placements (Details)                   HTML     33K 
63: R50         Equity Narrative (Details)                          HTML     83K 
64: R51         Equity Activity of Stock Options (Details)          HTML     78K 
65: R52         Equity Exercise Price Ranges (Details)              HTML     75K 
66: R53         Equity Summary of Unvested Stock Options (Details)  HTML     43K 
67: R54         Equity Assumptions (Details)                        HTML     40K 
68: R55         Equity Summary of Restricted Stock Awards           HTML     48K 
                (Details)                                                        
69: R56         Equity Recognized Stock-Based Compensation          HTML     33K 
                (Details)                                                        
70: R57         Income Taxes Deferred Tax Assets and Liabilities    HTML     51K 
                (Details)                                                        
71: R58         Income Taxes Reconciliation of the Federal          HTML     47K 
                Statutory Income Tax (Details)                                   
72: R59         Income Taxes Schedule of current and deferred       HTML     49K 
                income tax expense (Benefit) (Details)                           
73: R60         Income Taxes Reconciliation of unrecognized tax     HTML     28K 
                benefits (Details)                                               
74: R61         Income Taxes Narrative (Details)                    HTML     50K 
75: R62         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     61K 
                Investing and Financing Activities (Details)                     
76: R63         401k Plan (Details)                                 HTML     36K 
77: R64         Commitments and Contingencies Estimated Annual      HTML     34K 
                Lease, Royalty, and Employment Agreement Expenses                
                (Details)                                                        
78: R65         Commitments and Contingencies Narrative (Details)   HTML     65K 
79: R66         Quarterly Financial Data (Unaudited) (Details)      HTML     46K 
80: R67         Subsequent Events (Details)                         HTML     42K 
81: R68         Schedule II - Valuation and Qualifying Accounts     HTML     40K 
                (Details)                                                        
83: XML         IDEA XML File -- Filing Summary                      XML    142K 
82: EXCEL       IDEA Workbook of Financial Reports                  XLSX     93K 
 8: EX-101.INS  XBRL Instance -- mdxg-20151231                       XML   1.89M 
10: EX-101.CAL  XBRL Calculations -- mdxg-20151231_cal               XML    205K 
11: EX-101.DEF  XBRL Definitions -- mdxg-20151231_def                XML    539K 
12: EX-101.LAB  XBRL Labels -- mdxg-20151231_lab                     XML   1.71M 
13: EX-101.PRE  XBRL Presentations -- mdxg-20151231_pre              XML    937K 
 9: EX-101.SCH  XBRL Schema -- mdxg-20151231                         XSD    149K 
84: ZIP         XBRL Zipped Folder -- 0001376339-16-000138-xbrl      Zip    224K

‘EX-101.SCH’   —   XBRL Schema — mdxg-20151231

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL Document Created with Wdesk from Workiva -->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://mimedx.com/20151231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mdxg="http://mimedx.com/20151231" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
<xsd:import namespace="http://fasb.org/us-gaap/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd"/>
<xsd:import namespace="http://fasb.org/us-roles/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-roles-2015-01-31.xsd"/>
<xsd:import namespace="http://fasb.org/us-types/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-types-2015-01-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2013-01-31" schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2014-01-31" schemaLocation="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2015-01-31" schemaLocation="http://xbrl.sec.gov/exch/2015/exch-2015-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>
<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdxg-20151231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdxg-20151231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdxg-20151231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdxg-20151231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="A401KPlan" roleURI="http://mimedx.com/role/A401KPlan">
<link:definition> 2185100 - Disclosure - 401k Plan </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="A401KPlanDetails" roleURI="http://mimedx.com/role/A401KPlanDetails">
<link:definition> 2485401 - Disclosure - 401k Plan (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CashEquivalentsAndShortTermInvestments" roleURI="http://mimedx.com/role/CashEquivalentsAndShortTermInvestments">
<link:definition> 2104100 - Disclosure - Cash Equivalents and Short Term Investments </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CashEquivalentsAndShortTermInvestmentsDetails" roleURI="http://mimedx.com/role/CashEquivalentsAndShortTermInvestmentsDetails">
<link:definition> 2404401 - Disclosure - Cash Equivalents and Short Term Investments (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsAndContingencies" roleURI="http://mimedx.com/role/CommitmentsAndContingencies">
<link:definition> 2186100 - Disclosure - Commitments and Contingencies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsAndContingenciesEstimatedAnnualLeaseRoyaltyAndEmploymentAgreementExpensesDetails" roleURI="http://mimedx.com/role/CommitmentsAndContingenciesEstimatedAnnualLeaseRoyaltyAndEmploymentAgreementExpensesDetails">
<link:definition> 2486402 - Disclosure - Commitments and Contingencies Estimated Annual Lease, Royalty, and Employment Agreement Expenses (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsAndContingenciesNarrativeDetails" roleURI="http://mimedx.com/role/CommitmentsAndContingenciesNarrativeDetails">
<link:definition> 2486403 - Disclosure - Commitments and Contingencies Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsAndContingenciesTables" roleURI="http://mimedx.com/role/CommitmentsAndContingenciesTables">
<link:definition> 2386301 - Disclosure - Commitments and Contingencies (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommonStockPlacements" roleURI="http://mimedx.com/role/CommonStockPlacements">
<link:definition> 2155100 - Disclosure - Common Stock Placements </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommonStockPlacementsDetails" roleURI="http://mimedx.com/role/CommonStockPlacementsDetails">
<link:definition> 2455401 - Disclosure - Common Stock Placements (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ConsolidatedBalanceSheets" roleURI="http://mimedx.com/role/ConsolidatedBalanceSheets">
<link:definition> 1001000 - Statement - CONSOLIDATED BALANCE SHEETS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://mimedx.com/role/ConsolidatedBalanceSheetsParenthetical">
<link:definition> 1001501 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ConsolidatedStatementsOfCashFlows" roleURI="http://mimedx.com/role/ConsolidatedStatementsOfCashFlows">
<link:definition> 1004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ConsolidatedStatementsOfOperations" roleURI="http://mimedx.com/role/ConsolidatedStatementsOfOperations">
<link:definition> 1002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ConsolidatedStatementsOfStockholdersEquity" roleURI="http://mimedx.com/role/ConsolidatedStatementsOfStockholdersEquity">
<link:definition> 1003000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ConsolidatedStatementsOfStockholdersEquityParenthetical" roleURI="http://mimedx.com/role/ConsolidatedStatementsOfStockholdersEquityParenthetical">
<link:definition> 1003501 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DocumentAndEntityInformation" roleURI="http://mimedx.com/role/DocumentAndEntityInformation">
<link:definition> 0001000 - Document - Document and Entity Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="Equity" roleURI="http://mimedx.com/role/Equity">
<link:definition> 2160100 - Disclosure - Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquityActivityOfStockOptionsDetails" roleURI="http://mimedx.com/role/EquityActivityOfStockOptionsDetails">
<link:definition> 2460403 - Disclosure - Equity Activity of Stock Options (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquityAssumptionsDetails" roleURI="http://mimedx.com/role/EquityAssumptionsDetails">
<link:definition> 2460406 - Disclosure - Equity Assumptions (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquityExercisePriceRangesDetails" roleURI="http://mimedx.com/role/EquityExercisePriceRangesDetails">
<link:definition> 2460404 - Disclosure - Equity Exercise Price Ranges (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquityNarrativeDetails" roleURI="http://mimedx.com/role/EquityNarrativeDetails">
<link:definition> 2460402 - Disclosure - Equity Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquityRecognizedStockBasedCompensationDetails" roleURI="http://mimedx.com/role/EquityRecognizedStockBasedCompensationDetails">
<link:definition> 2460408 - Disclosure - Equity Recognized Stock-Based Compensation (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquitySummaryOfRestrictedStockAwardsDetails" roleURI="http://mimedx.com/role/EquitySummaryOfRestrictedStockAwardsDetails">
<link:definition> 2460407 - Disclosure - Equity Summary of Restricted Stock Awards (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquitySummaryOfUnvestedStockOptionsDetails" roleURI="http://mimedx.com/role/EquitySummaryOfUnvestedStockOptionsDetails">
<link:definition> 2460405 - Disclosure - Equity Summary of Unvested Stock Options (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquityTables" roleURI="http://mimedx.com/role/EquityTables">
<link:definition> 2360301 - Disclosure - Equity (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxes" roleURI="http://mimedx.com/role/IncomeTaxes">
<link:definition> 2165100 - Disclosure - Income Taxes </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" roleURI="http://mimedx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails">
<link:definition> 2465402 - Disclosure - Income Taxes Deferred Tax Assets and Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://mimedx.com/role/IncomeTaxesNarrativeDetails">
<link:definition> 2465406 - Disclosure - Income Taxes Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxDetails" roleURI="http://mimedx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxDetails">
<link:definition> 2465403 - Disclosure - Income Taxes Reconciliation of the Federal Statutory Income Tax (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetails" roleURI="http://mimedx.com/role/IncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetails">
<link:definition> 2465405 - Disclosure - Income Taxes Reconciliation of unrecognized tax benefits (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesScheduleOfCurrentAndDeferredIncomeTaxExpenseBenefitDetails" roleURI="http://mimedx.com/role/IncomeTaxesScheduleOfCurrentAndDeferredIncomeTaxExpenseBenefitDetails">
<link:definition> 2465404 - Disclosure - Income Taxes Schedule of current and deferred income tax expense (benefit) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesTables" roleURI="http://mimedx.com/role/IncomeTaxesTables">
<link:definition> 2365301 - Disclosure - Income Taxes (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IntangibleAssetsAndRoyaltyAgreement" roleURI="http://mimedx.com/role/IntangibleAssetsAndRoyaltyAgreement">
<link:definition> 2108100 - Disclosure - Intangible Assets and Royalty Agreement </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IntangibleAssetsAndRoyaltyAgreementExpectedFutureAmortizationOfIntangibleAssetsDetails" roleURI="http://mimedx.com/role/IntangibleAssetsAndRoyaltyAgreementExpectedFutureAmortizationOfIntangibleAssetsDetails">
<link:definition> 2408403 - Disclosure - Intangible Assets and Royalty Agreement Expected Future Amortization of Intangible Assets (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IntangibleAssetsAndRoyaltyAgreementIntangibleAsssetsActivitySummaryDetails" roleURI="http://mimedx.com/role/IntangibleAssetsAndRoyaltyAgreementIntangibleAsssetsActivitySummaryDetails">
<link:definition> 2408402 - Disclosure - Intangible Assets and Royalty Agreement Intangible Asssets Activity Summary (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IntangibleAssetsAndRoyaltyAgreementTables" roleURI="http://mimedx.com/role/IntangibleAssetsAndRoyaltyAgreementTables">
<link:definition> 2308301 - Disclosure - Intangible Assets and Royalty Agreement (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="Inventories" roleURI="http://mimedx.com/role/Inventories">
<link:definition> 2105100 - Disclosure - Inventories </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="InventoriesDetails" roleURI="http://mimedx.com/role/InventoriesDetails">
<link:definition> 2405402 - Disclosure - Inventories (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="InventoriesTables" roleURI="http://mimedx.com/role/InventoriesTables">
<link:definition> 2305301 - Disclosure - Inventories (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="Investments" roleURI="http://mimedx.com/role/Investments">
<link:definition> 2106100 - Disclosure - Investments </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="InvestmentsDetails" roleURI="http://mimedx.com/role/InvestmentsDetails">
<link:definition> 2406401 - Disclosure - Investments (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LiquidityAndCapitalResources" roleURI="http://mimedx.com/role/LiquidityAndCapitalResources">
<link:definition> 2103100 - Disclosure - Liquidity and Capital Resources </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LiquidityAndCapitalResourcesDetails" roleURI="http://mimedx.com/role/LiquidityAndCapitalResourcesDetails">
<link:definition> 2403401 - Disclosure - Liquidity and Capital Resources (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LongTermDebt" roleURI="http://mimedx.com/role/LongTermDebt">
<link:definition> 2109100 - Disclosure - Long-Term Debt </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LongTermDebtDetails" roleURI="http://mimedx.com/role/LongTermDebtDetails">
<link:definition> 2409401 - Disclosure - Long-Term Debt (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="NatureOfBusiness" roleURI="http://mimedx.com/role/NatureOfBusiness">
<link:definition> 2101100 - Disclosure - Nature of Business </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="NatureOfBusinessDetails" roleURI="http://mimedx.com/role/NatureOfBusinessDetails">
<link:definition> 2401401 - Disclosure - Nature of Business (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="NetIncomeLossPerShare" roleURI="http://mimedx.com/role/NetIncomeLossPerShare">
<link:definition> 2110100 - Disclosure - Net Income (loss) Per Share </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="NetIncomeLossPerShareComputationOfBasicAndDilutiveNetLossPerShareDetails" roleURI="http://mimedx.com/role/NetIncomeLossPerShareComputationOfBasicAndDilutiveNetLossPerShareDetails">
<link:definition> 2410402 - Disclosure - Net Income (loss) Per Share Computation of Basic and Dilutive Net Loss per Share (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="NetIncomeLossPerShareSummaryOfAntidilutiveSecuritiesDetails" roleURI="http://mimedx.com/role/NetIncomeLossPerShareSummaryOfAntidilutiveSecuritiesDetails">
<link:definition> 2410403 - Disclosure - Net Income (loss) Per Share Summary of Antidilutive Securities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="NetIncomeLossPerShareTables" roleURI="http://mimedx.com/role/NetIncomeLossPerShareTables">
<link:definition> 2310301 - Disclosure - Net Income (loss) Per Share (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="PropertyAndEquipment" roleURI="http://mimedx.com/role/PropertyAndEquipment">
<link:definition> 2107100 - Disclosure - Property and Equipment </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="PropertyAndEquipmentDetails" roleURI="http://mimedx.com/role/PropertyAndEquipmentDetails">
<link:definition> 2407402 - Disclosure - Property and Equipment (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="PropertyAndEquipmentTables" roleURI="http://mimedx.com/role/PropertyAndEquipmentTables">
<link:definition> 2307301 - Disclosure - Property and Equipment (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="QuarterlyFinancialDataUnaudited" roleURI="http://mimedx.com/role/QuarterlyFinancialDataUnaudited">
<link:definition> 2187100 - Disclosure - Quarterly Financial Data (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="QuarterlyFinancialDataUnauditedDetails" roleURI="http://mimedx.com/role/QuarterlyFinancialDataUnauditedDetails">
<link:definition> 2487402 - Disclosure - Quarterly Financial Data (Unaudited) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="QuarterlyFinancialDataUnauditedTables" roleURI="http://mimedx.com/role/QuarterlyFinancialDataUnauditedTables">
<link:definition> 2387301 - Disclosure - Quarterly Financial Data (Unaudited) (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ScheduleIiValuationAndQualifyingAccounts" roleURI="http://mimedx.com/role/ScheduleIiValuationAndQualifyingAccounts">
<link:definition> 2189100 - Schedule - Schedule II - Valuation and Qualifying Accounts </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ScheduleIiValuationAndQualifyingAccountsDetails" roleURI="http://mimedx.com/role/ScheduleIiValuationAndQualifyingAccountsDetails">
<link:definition> 2489401 - Schedule - Schedule II - Valuation and Qualifying Accounts (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SignificantAccountingPolicies" roleURI="http://mimedx.com/role/SignificantAccountingPolicies">
<link:definition> 2102100 - Disclosure - Significant Accounting Policies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SignificantAccountingPoliciesDetails" roleURI="http://mimedx.com/role/SignificantAccountingPoliciesDetails">
<link:definition> 2402402 - Disclosure - Significant Accounting Policies (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://mimedx.com/role/SignificantAccountingPoliciesPolicies">
<link:definition> 2202201 - Disclosure - Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SubsequentEvents" roleURI="http://mimedx.com/role/SubsequentEvents">
<link:definition> 2188100 - Disclosure - Subsequent Events </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SubsequentEventsDetails" roleURI="http://mimedx.com/role/SubsequentEventsDetails">
<link:definition> 2488401 - Disclosure - Subsequent Events (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SupplementalDisclosureOfCashFlowAndNonCashInvestingAndFinancingActivities" roleURI="http://mimedx.com/role/SupplementalDisclosureOfCashFlowAndNonCashInvestingAndFinancingActivities">
<link:definition> 2170100 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SupplementalDisclosureOfCashFlowAndNonCashInvestingAndFinancingActivitiesDetails" roleURI="http://mimedx.com/role/SupplementalDisclosureOfCashFlowAndNonCashInvestingAndFinancingActivitiesDetails">
<link:definition> 2470402 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SupplementalDisclosureOfCashFlowAndNonCashInvestingAndFinancingActivitiesTables" roleURI="http://mimedx.com/role/SupplementalDisclosureOfCashFlowAndNonCashInvestingAndFinancingActivitiesTables">
<link:definition> 2370301 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="mdxg_AllowanceforObsolescenceMember" name="AllowanceforObsolescenceMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_BoneBankActionMember" name="BoneBankActionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationConsiderationTransferredPaidinCashPercent" name="BusinessCombinationConsiderationTransferredPaidinCashPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationConsiderationTransferredPaidinCommonStockPercent" name="BusinessCombinationConsiderationTransferredPaidinCommonStockPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationConsiderationTransferredReceivableWriteoffs" name="BusinessCombinationConsiderationTransferredReceivableWriteoffs" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationContingentConsiderationArrangementsTerm" name="BusinessCombinationContingentConsiderationArrangementsTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationContingentConsiderationArrangementstoBeSettledInCashPercent" name="BusinessCombinationContingentConsiderationArrangementstoBeSettledInCashPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationContingentConsiderationArrangementstoBeSettledInSharesOfCommonStockPercent" name="BusinessCombinationContingentConsiderationArrangementstoBeSettledInSharesOfCommonStockPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_CommonStockAndWarrantsPrivatePlacementTable" name="CommonStockAndWarrantsPrivatePlacementTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_ConsultantMember" name="ConsultantMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_ContingentRoyaltyToBePaidToLicensor" name="ContingentRoyaltyToBePaidToLicensor" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="mdxg_CreditAgreementMember" name="CreditAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_CurrentAssetsandLiabilitiesNet" name="CurrentAssetsandLiabilitiesNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element id="mdxg_DebtInstrumentConvertibleNumberOfShares" name="DebtInstrumentConvertibleNumberOfShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_DeferredTaxAssetsFederalandStateBasisDifference" name="DeferredTaxAssetsFederalandStateBasisDifference" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element id="mdxg_DeferredTaxAssetsthatWouldImpactEquitySharebasedCompensation" name="DeferredTaxAssetsthatWouldImpactEquitySharebasedCompensation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element id="mdxg_DefinedBenefitPlanMaximumPreTaxContributionsByPlanParticipants" name="DefinedBenefitPlanMaximumPreTaxContributionsByPlanParticipants" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_DefinedContributionPlanMaximumPercentageOfEligibleWagesDeferredByParticipants" name="DefinedContributionPlanMaximumPercentageOfEligibleWagesDeferredByParticipants" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_FirstCustomerMember" name="FirstCustomerMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" name="FivePercentConvertibleSeniorSecuredPromissoryNoteMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_ImpairmentofIntangibleAssets" name="ImpairmentofIntangibleAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_IntangibleAssetsAccumulatedAmortization" name="IntangibleAssetsAccumulatedAmortization" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="mdxg_LeaseholdImprovementsPaidbyOthersMember" name="LeaseholdImprovementsPaidbyOthersMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_LineofCreditFacilityUncommittedIncrementalFacility" name="LineofCreditFacilityUncommittedIncrementalFacility" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="mdxg_LiquidityandCapitalResourcesAbstract" name="LiquidityandCapitalResourcesAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_LiquidityandCapitalResourcesTextBlock" name="LiquidityandCapitalResourcesTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_LiventaAction437PatentMember" name="LiventaAction437PatentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_LiventaAction701PatentMember" name="LiventaAction701PatentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_LiventaActionMember" name="LiventaActionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_LoanAgreementMember" name="LoanAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_LossContingencyPendingClaimsAllowedforReviewNumber" name="LossContingencyPendingClaimsAllowedforReviewNumber" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
<xsd:element id="mdxg_LossContingencyPendingDisputedClaimTermsNumber" name="LossContingencyPendingDisputedClaimTermsNumber" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
<xsd:element id="mdxg_LossContingencyPeriodforPlaintifftoProceed" name="LossContingencyPeriodforPlaintifftoProceed" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_MaximumEligibleWagesDeferredByParticipantsPerYear" name="MaximumEligibleWagesDeferredByParticipantsPerYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_MinimumAgeForAdditionalContributionBeyondNormalPlan" name="MinimumAgeForAdditionalContributionBeyondNormalPlan" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_MinimumAgeRequireToQualifyForPensionPlan" name="MinimumAgeRequireToQualifyForPensionPlan" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_MinimumServicePeriodRequireToQualifyForPensionPlan" name="MinimumServicePeriodRequireToQualifyForPensionPlan" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_NumberOfMajorCustomers" name="NumberOfMajorCustomers" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
<xsd:element id="mdxg_NumberOfShareBasedCompensationPlans" name="NumberOfShareBasedCompensationPlans" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_OutstandingAssumedOptions" name="OutstandingAssumedOptions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="mdxg_PatentsinProcessMember" name="PatentsinProcessMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_PaymentsforApplicationCostsPatent" name="PaymentsforApplicationCostsPatent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_PaymentsofStockRepurchaseCosts" name="PaymentsofStockRepurchaseCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_PeriodOfApprovalMaximum" name="PeriodOfApprovalMaximum" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_PlacementFee" name="PlacementFee" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_PriceRange1Member" name="PriceRange1Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_PriceRange2Member" name="PriceRange2Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_PriceRange3Member" name="PriceRange3Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_PriceRange4Member" name="PriceRange4Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_PriceRange5Member" name="PriceRange5Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_PriceRange6Member" name="PriceRange6Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_PriceRange7Member" name="PriceRange7Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_RetirementofFixedAssets" name="RetirementofFixedAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_SaleOfStocksAndWarrantsLineItems" name="SaleOfStocksAndWarrantsLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_ScheduleOfIntangibleAssetsActivityTableTextBlock" name="ScheduleOfIntangibleAssetsActivityTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_ShrinersHospitalsForChildrenAndUniversityOfSouthFloridaResearchFoundationInc.Member" name="ShrinersHospitalsForChildrenAndUniversityOfSouthFloridaResearchFoundationInc.Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_StabilityBiologicsLLCMember" name="StabilityBiologicsLLCMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_StockIssuedDuringPeriodSharesExerciseOfWarrants" name="StockIssuedDuringPeriodSharesExerciseOfWarrants" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_StockIssuedDuringPeriodSharesForEarnOutLiability" name="StockIssuedDuringPeriodSharesForEarnOutLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_StockIssuedDuringPeriodValueExerciseOfWarrants" name="StockIssuedDuringPeriodValueExerciseOfWarrants" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_StockIssuedDuringPeriodValueForEarnOutLiability" name="StockIssuedDuringPeriodValueForEarnOutLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_SurgicalBiologicsMember" name="SurgicalBiologicsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_UnpaidInterestToBeConsideredForConversionInToSharesOfCommonStock" name="UnpaidInterestToBeConsideredForConversionInToSharesOfCommonStock" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_UnrecognizedTaxBenefitsthatWouldImpactOtherTaxAccounts" name="UnrecognizedTaxBenefitsthatWouldImpactOtherTaxAccounts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_WarrantExercisePrice" name="WarrantExercisePrice" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_WarrantsTerm" name="WarrantsTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
</xsd:schema>

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/25/17  SEC                               UPLOAD9/28/17    1:41K  Mimedx Group, Inc.
 1/09/17  SEC                               UPLOAD9/28/17    1:41K  Mimedx Group, Inc.
12/06/16  SEC                               UPLOAD9/28/17    1:139K Mimedx Group, Inc.
10/31/16  SEC                               UPLOAD9/28/17    1:169K Mimedx Group, Inc.
↑Top
Filing Submission 0001376339-16-000138   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., Apr. 28, 9:00:31.1pm ET